vs
Side-by-side financial comparison of COASTAL FINANCIAL CORP (CCB) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.
Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $138.0M, roughly 1.0× COASTAL FINANCIAL CORP). On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -5.8%). COASTAL FINANCIAL CORP produced more free cash flow last quarter ($246.1M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs -3.6%).
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.
CCB vs TOI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $138.0M | $142.0M |
| Net Profit | — | $-7.5M |
| Gross Margin | — | — |
| Operating Margin | 12.4% | -4.9% |
| Net Margin | — | -5.3% |
| Revenue YoY | -5.8% | 41.6% |
| Net Profit YoY | — | 43.0% |
| EPS (diluted) | $0.84 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $138.0M | $142.0M | ||
| Q3 25 | $144.7M | $136.6M | ||
| Q2 25 | $119.4M | $119.8M | ||
| Q1 25 | $139.5M | $104.4M | ||
| Q4 24 | $146.5M | $100.3M | ||
| Q3 24 | $151.1M | $99.9M | ||
| Q2 24 | $135.3M | $98.6M | ||
| Q1 24 | $148.4M | $94.7M |
| Q4 25 | — | $-7.5M | ||
| Q3 25 | $13.6M | $-16.5M | ||
| Q2 25 | $11.0M | $-17.0M | ||
| Q1 25 | $9.7M | $-19.6M | ||
| Q4 24 | — | $-13.2M | ||
| Q3 24 | $13.5M | $-16.1M | ||
| Q2 24 | $11.6M | $-15.5M | ||
| Q1 24 | $6.8M | $-19.9M |
| Q4 25 | 12.4% | -4.9% | ||
| Q3 25 | 12.4% | -5.9% | ||
| Q2 25 | 12.0% | -9.4% | ||
| Q1 25 | 8.4% | -9.5% | ||
| Q4 24 | 11.7% | -11.9% | ||
| Q3 24 | 10.8% | -13.9% | ||
| Q2 24 | 11.1% | -16.6% | ||
| Q1 24 | 5.9% | -19.0% |
| Q4 25 | — | -5.3% | ||
| Q3 25 | 9.4% | -12.1% | ||
| Q2 25 | 9.2% | -14.2% | ||
| Q1 25 | 7.0% | -18.8% | ||
| Q4 24 | — | -13.1% | ||
| Q3 24 | 8.9% | -16.1% | ||
| Q2 24 | 8.6% | -15.7% | ||
| Q1 24 | 4.6% | -21.0% |
| Q4 25 | $0.84 | $-0.04 | ||
| Q3 25 | $0.88 | $-0.14 | ||
| Q2 25 | $0.71 | $-0.15 | ||
| Q1 25 | $0.63 | $-0.21 | ||
| Q4 24 | $0.95 | $-0.14 | ||
| Q3 24 | $0.97 | $-0.18 | ||
| Q2 24 | $0.84 | $-0.17 | ||
| Q1 24 | $0.50 | $-0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $491.0M | $-15.7M |
| Total Assets | $4.7B | $164.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $9.9M | ||
| Q1 24 | — | $29.8M |
| Q4 25 | $491.0M | $-15.7M | ||
| Q3 25 | $475.3M | $-12.3M | ||
| Q2 25 | $461.7M | $-9.0M | ||
| Q1 25 | $449.9M | $5.1M | ||
| Q4 24 | $438.7M | $3.6M | ||
| Q3 24 | $331.9M | $15.5M | ||
| Q2 24 | $316.7M | $29.2M | ||
| Q1 24 | $303.7M | $41.3M |
| Q4 25 | $4.7B | $164.7M | ||
| Q3 25 | $4.6B | $163.6M | ||
| Q2 25 | $4.5B | $159.8M | ||
| Q1 25 | $4.3B | $164.0M | ||
| Q4 24 | $4.1B | $172.7M | ||
| Q3 24 | $4.1B | $179.2M | ||
| Q2 24 | $4.0B | $179.6M | ||
| Q1 24 | $3.9B | $204.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $254.6M | $3.2M |
| Free Cash FlowOCF − Capex | $246.1M | $2.2M |
| FCF MarginFCF / Revenue | 178.3% | 1.5% |
| Capex IntensityCapex / Revenue | 6.1% | 0.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $436.4M | $-27.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $254.6M | $3.2M | ||
| Q3 25 | $59.0M | $-12.6M | ||
| Q2 25 | $66.0M | $-10.2M | ||
| Q1 25 | $71.7M | $-5.0M | ||
| Q4 24 | $259.8M | $4.2M | ||
| Q3 24 | $62.6M | $819.0K | ||
| Q2 24 | $72.1M | $-15.7M | ||
| Q1 24 | $56.8M | $-15.9M |
| Q4 25 | $246.1M | $2.2M | ||
| Q3 25 | $57.4M | $-13.2M | ||
| Q2 25 | $64.0M | $-11.4M | ||
| Q1 25 | $68.9M | $-5.3M | ||
| Q4 24 | $249.9M | $2.4M | ||
| Q3 24 | $60.2M | $417.0K | ||
| Q2 24 | $69.5M | $-17.5M | ||
| Q1 24 | $55.0M | $-16.5M |
| Q4 25 | 178.3% | 1.5% | ||
| Q3 25 | 39.7% | -9.7% | ||
| Q2 25 | 53.6% | -9.5% | ||
| Q1 25 | 49.4% | -5.1% | ||
| Q4 24 | 170.6% | 2.4% | ||
| Q3 24 | 39.8% | 0.4% | ||
| Q2 24 | 51.3% | -17.7% | ||
| Q1 24 | 37.1% | -17.4% |
| Q4 25 | 6.1% | 0.7% | ||
| Q3 25 | 1.2% | 0.4% | ||
| Q2 25 | 1.7% | 1.0% | ||
| Q1 25 | 2.0% | 0.3% | ||
| Q4 24 | 6.8% | 1.8% | ||
| Q3 24 | 1.6% | 0.4% | ||
| Q2 24 | 1.9% | 1.9% | ||
| Q1 24 | 1.2% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | 4.34× | — | ||
| Q2 25 | 5.99× | — | ||
| Q1 25 | 7.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.65× | — | ||
| Q2 24 | 6.22× | — | ||
| Q1 24 | 8.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
TOI
| Other | $82.1M | 58% |
| Fee For Service | $36.3M | 26% |
| Capitated Revenue | $23.6M | 17% |
